The following information was taken from the 2012 annual report of Bristol-Myers Squibb, a world- leading drug company (dollars in millions).

Prepare an income statement, balance sheet, and statement of cash flows, and comment on the financial performance and condition of the company.

Transcribed Image Text:

Cost of goods sold Net cash from operations Accounts receivable Impairment expense Net cash from financing Shareholders' equity Net cash from investing Research and dev. expense Other noncurrent assets Other expenses/(gain) Marketable securities $ 4,610 6,941 3,083 1,830 (4,333) 13,638 (6,727) 3,904 21,043 (241) 1,173 Cash and equivalents Short-term borrowings Advertising and product expense Accounts payable Long-term liabilities Net sales Property, plant, and equipment Other current assets Other current liabilities Selling and adm. expenses Accrued payables $1,656 826 797 2,202 13,980 17,621 5,333 3,609 2,678 4,220 2,573